TL;DR: Haruspex AI identified a strong bullish market bias on June 24, 2026, with 130 buy signals against only 11 bearish. Market participants found significant directional edges in pharmaceuticals and semiconductors, led by LLY and NVDA, suggesting continued upside in specific growth areas.
On Wednesday, June 24, 2026, ET, Haruspex analysis recorded a decisive bullish market sentiment, with 130 stocks showing strong positive directional pressure across a total of 174 analyzed companies. This strong bias overshadowed a broader market dip, with the S&P 500 closing down 1.44%, indicating a highly selective market focusing on specific pockets of strength.
The most compelling data insight of the day was the significant imbalance between bullish and bearish signals. While the S&P 500 pulled back to 7365.46 [data: 2026-06-24 close], 75% of individual stocks tracked by Haruspex registered bullish directional signals. This suggests underlying buyer accumulation in a substantial portion of the market, even amidst broader index weakness.
Macro Regime Monitor
The overall market environment displayed a mix of risk-off sentiment in the broad index, contrasted by contained volatility and stable long-term yields.
| Metric | Current | Key Level |
|---|---|---|
| S&P 500 | 7365.46 [data: 2026-06-24 close] | 7400.00 |
| VIX | 18.97 [data: 2026-06-24 close] | 20.00 |
| 10Y Treasury Yield | 4.44% [data: 2026-06-24 close] | 4.50% |
| WTI Crude Oil | $71.09 [data: 2026-06-24 close] | $70.00 |
| US Dollar Index (DXY) | 101.77 [data: 2026-06-24 close] | 102.00 |
The VIX, currently at 18.97 [data: 2026-06-24 close], remained below the 20.00 threshold, indicating that despite the S&P 500's decline, market participants do not foresee an immediate surge in extreme volatility. This could empower selective buying in high-conviction areas.
Why did bullish pressure surge across diverse sectors?
Haruspex detected a strong confluence of positive signals from core fundamental and technical dimensions, indicating that sector-specific catalysts and robust corporate performance are overriding general market hesitancy. The significant number of bullish signals across pharmaceuticals, semiconductors, and even consumer staples underscores a flight to quality and growth in areas supported by strong earnings and institutional conviction.
What Haruspex Detected
Haruspex’s AI employs a sophisticated framework, analyzing hundreds of data points across multiple dimensions. This approach allows it to identify subtle market pressures that conventional single-metric analysis often misses. Today, the system pinpointed strong bullish directional signals across key growth and defensive sectors, driven by robust performance in specific AI dimensions.
- Eli Lilly and Company (LLY) recorded a strong bullish market pressure score of 81.0, a +1.0 point increase. This was primarily driven by the `earnings` dimension, which registered an 85, reflecting robust financial reporting and forward guidance. The `competitors` dimension (75) and `institutional` dimension (68) also contributed significantly, indicating strong peer performance relative to LLY and sustained institutional interest.
- Moderna Inc. (MRNA) surged with a score of 81.0, marking a notable +9.0 point change. This substantial move was underpinned by strong signals across the `earnings` dimension (72), `options_flow` dimension (72), and `technical` dimension (72). This combination suggests both fundamental strength and aggressive bullish positioning in the derivatives market, confirming strong buyer conviction.
- NVIDIA Corporation (NVDA) maintained strong bullish market pressure with a score of 81.0, an increase of +4.0 points. The `earnings` dimension, at 82, and the `competitors` dimension, at 78, indicated robust sector performance and continued market dominance. The `institutional` dimension (72) further highlighted sustained large-scale investor confidence in NVDA's growth trajectory, reflecting a strong buyer-seller imbalance.
- Lam Research Corporation (LRCX) achieved a score of 80.0, up +1.0 point. Key drivers included the `earnings` dimension (78), signaling solid financial health, and the `short_interest` dimension (70), suggesting a potential for short covering. The `options_flow` dimension (68) also showed bullish activity, contributing to positive market pressure signals.
- Chubb Limited (CB) registered a bullish market pressure score of 79.0, climbing +2.0 points. This strength was broadly supported by the `earnings` dimension (72), the `options_flow` dimension (72), and the `short_interest` dimension (72). This indicates strong accumulation and favorable positioning by market participants, with reduced downside from short positions.
- Morgan Stanley (MS) showed a bullish score of 79.0, rising +2.0 points. Haruspex detected robust market pressure driven by the `earnings` dimension (72) and consistent `institutional` interest (70). The `short_interest` dimension (70) also contributed, suggesting potential for upward momentum as existing short positions may face pressure.
- Merck & Co. Inc. (MRK) experienced a significant jump of +13.0 points, reaching a strong bullish score of 77.0. This notable shift was primarily fueled by strong signals in the `earnings` dimension (72), `institutional` dimension (72), and `options_flow` dimension (72). The substantial increase suggests a re-evaluation of MRK's prospects by large investors and derivatives traders.
Risk Factors
Despite widespread individual stock strength, several factors could shift the current bullish thesis. A persistent S&P 500 decline, such as a close below 7300 for three consecutive sessions, could erode broader investor confidence and translate into selling pressure on even top-scoring stocks. Furthermore, a sudden spike in the VIX above 22.00 could signal increased systemic risk, prompting a broad market pullback.
Geopolitical tensions or unexpected shifts in interest rate policy from the Federal Reserve also represent significant external risks. Should the 10-year Treasury yield unexpectedly surge past 4.60% for a full week, it could reintroduce concerns about higher discount rates, impacting growth stock valuations. Commodity price instability, particularly a WTI Crude Oil spike above $75.00, might trigger inflation fears and consumer spending concerns.
What Would Change This View
The current bullish market pressure thesis, despite the daily S&P 500 dip, is contingent on several measurable conditions. If the S&P 500 were to close below its 50-day moving average on volume exceeding the 20-day average by 20% for two consecutive days, it would indicate a significant shift in broad market sentiment, challenging current bullish signals.
A sustained increase in the US Dollar Index (DXY) above 102.50 for a full trading week could signal tightening global liquidity or increased safe-haven demand, typically bearish for risk assets. Additionally, if the proportion of bearish signals detected by Haruspex AI exceeds 25% of all analyzed stocks (i.e., more than 43 bearish signals) for five consecutive days, it would invalidate the current outlook of widespread underlying strength.
Outlook
Haruspex analysis points to a highly selective market environment where strong fundamental drivers and specific market flows are creating substantial directional edges for individual stocks. While the broader indices may experience volatility, the significant number of bullish signals (130 out of 174) indicates that discerning investors are finding opportunities. This divergence suggests that stock-picking based on robust AI-detected dimensions will remain critical in the near term.
We anticipate continued focus on companies exhibiting strong `earnings` performance and positive `options_flow`, alongside favorable `institutional` positioning. Sectors such as pharmaceuticals and semiconductors, led by names like LLY, MRNA, and NVDA, are poised to maintain their bullish momentum as long as their specific AI dimensions remain elevated and macro indicators like the VIX stay contained. This reinforces a 'growth at a reasonable price' narrative within a complex market structure.
